Redmile Group’s ALX Oncology ALXO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.41M | Sell |
|
|||||
|
2025
Q1 | $2.27M | Sell |
|
|||||
|
2024
Q4 | $6.16M | Sell |
|
|||||
|
2024
Q3 | $6.98M | Sell |
|
|||||
|
2024
Q2 | $24.3M | Sell |
|
|||||
|
2024
Q1 | $48.2M | Buy |
|
|||||
|
2023
Q4 | $54.5M | Buy |
|
|||||
|
2023
Q3 | $6.16M | Hold |
|
|||||
|
2023
Q2 | $9.64M | Buy |
|
|||||
|
2023
Q1 | $2.65M | Sell |
|
|||||
|
2022
Q4 | $6.85M | Sell |
|
|||||
|
2022
Q3 | $7.2M | Sell |
|
|||||
|
2022
Q2 | $6.2M | Sell |
|
|||||
|
2022
Q1 | $13.1M | Sell |
|
|||||
|
2021
Q4 | $16.8M | Sell |
|
|||||
|
2021
Q3 | $63.8M | Sell |
|
|||||
|
2021
Q2 | $50M | Sell |
|
|||||
|
2021
Q1 | $72.2M | Buy |
|
|||||
|
2020
Q4 | $82.8M | Buy |
|
|||||
|
2020
Q3 | $15.4M | Buy |
|